Curnutte John T 4
4 · Orchard Therapeutics plc · Filed Jun 17, 2021
Insider Transaction Report
Form 4
Curnutte John T
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-16+40,000→ 40,000 totalExercise: $4.79Exp: 2031-06-15→ Ordinary Shares (40,000 underlying)
Footnotes (2)
- [F1]All of the shares subject to this option vest upon the earlier to occur of June 16, 2022 or the date of the 2022 Annual General Meeting of the Company.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.